Aros Pharma ApS develops therapies for reducing the pain associated with Irritable Bowel Syndrome (IBS)
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Copenhagen
State: Hovedstaden
Zip:
Country: Denmark
Aros Pharma is developing a new effective therapy reducing the pain associated with Irritable Bowel Syndrome (IBS). The company has acquired all rights to a new chemical entity that can negatively modulate the activity of acid sensors in the gastrointestinal tract. These acid sensors are believed to play a central role in pain associated with IBS.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2010 | Venture Round | 1 | - |
Seed Capital Seed Capital |
12/2010 | Venture Round | 1 | - |
Seed Capital Seed Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|